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The Abnormal Blood Profile Score (ABPS) is used to identify blood doping in sport.
It combines seven hematological markers, including hemoglobin level, reticulocytes
percent, and haematocrit level, using two different machine learning algorithms in order
to create a single score that has a better ability to identify doping than each parameter
taken alone. The resulting score allows the detection of several types of doping using a
single score and is part of the current Athlete Biological Passport program managed by
World Anti-Doping Agency (WADA). We describe≪ ABPS≫, an R package that allows
the calculation of this score. This is the first software implementation calculating this score
that is released publicly. The package also contains functions to calculate the OFF-score
(another score used for detection of doping), as well as several test datasets. The
package is useful for laboratories conducting anti-doping analyses and for researchers
working on anti-doping research projects. In particular, it has been successfully used in
projects estimating the prevalence of blood doping.
Keywords: code:R, anti-doping, ABPS, blood doping, machine learning
INTRODUCTION
The Abnormal Blood Profile Score (ABPS) is one of several tools used to identify blood doping in
elite athletes. Originally developed at the Swiss Laboratory for Doping Analyses (LAD) in Lausanne
(Sottas et al., 2006), it combines 7 hematological markers (reticulocytes percent, hemoglobin level,
haematocrit level, red blood cell count, mean corpuscular volume, mean corpuscular hemoglobin,
mean corpuscular hemoglobin concentration) into a single score. According to the original ABPS
publication, this combined score is more sensitive (for the same level of specificity) to doping than
any of these blood parameters taken separately; in particular, the ABPS alone allows the detection
of several types of blood doping (Sottas et al., 2006). ABPS is based on two different classification
techniques, a naive Bayesian classifier and an SVM (Support Vector Machine). The two models
were trained using a database of 591 blood profiles (including 402 control samples from clean
athletes and 189 samples of athletes who abused of an illegal substance); the two scores were
then combined using a method called ≪ ensemble averaging ≫ to obtain the final score. The
resulting ABPS values are unitless; based on a large collection of test results (>3,000 samples),
they typically range between −2.35 and 1 (95% confidence interval, with a mean of −0.67 and a
standard deviation of 0.87); more detailed reference distributions and the effect of different factors
(sex and age of athlete, type of sport, etc) on the score is described elsewhere (Robinson et al., 2018).
While ABPS is not a primary marker of doping, it has been used as corroborative evidence (CAS,
2012) and it is part of the Athlete Biological Passport (ABP) program managed by the World Anti-
Doping Agency (WADA; Sottas et al., 2011a). Assuming that the testing was conducted according
to the WADA guidelines (WADA, 2018), scores between 0 and 1 indicate a possible suspicion of
doping (CAS, 2012); a score above 1 should be found only in 1 in 1,000 clean male athletes.
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Several versions of ABPS scoring have been developed over
the years, using up to 12 different blood parameters (Sottas et al.,
2010); however, the most commonly used version is based on the
7 parameters described above, which can be obtained “on-line”
on a portable analyzer. The 7 parameters were selected following
a comparison of the performances of models with different
numbers of parameters. The original ABPS implementation was
created using the Matlab programming language, and WADA
maintains a Java version that is used within the ADAMS (Anti-
Doping Administration and Management System) database and
the Athlete Biological Passport program. However, these versions
are only available to anti-doping organizations recognized by
WADA.
THE R PACKAGE ABPS
The ABPS package allows users to compute the Abnormal
Blood Profile Score using the R statistical software (R Core
Team, 2017). It is the first such software implementation that
is released publicly. The R software was implemented using
the original Matlab software as a reference; in particular, no
new model fitting was performed, as the original parameters
calculated in Matlab for the naive Bayesian and the SVM
classifiers were reused in the R code. As a result, the package
does not require the original database of blood profiles, which
is not publicly available. The concordance of results obtained
using the Matlab software and the R implementation was
checked using a series of test data, some of which are included
in the package (see section ≪ datasets ≫ below for more
details).
The ABPS function available in the package requires the
user to provide values for the seven hematological markers for
one or several samples, and will then calculate and return the
corresponding score or scores. The markers can be specified
either as a single data frame (the basic structure for managing
data in R) containing the seven parameters, or by specifying
separately the seven following variables (the expected units
are indicated): HCT [haematocrit level, in [%]], HGB [the
hemoglobin level, in [g/dL]], MCH [the mean corpuscular
hemoglobin, in [pg]], MCHC [the mean corpuscular hemoglobin
concentration, in [g/dL]], MCV [the Mean corpuscular volume,
in [fL]], RBC [the red blood cell count, in [106/ µL]], RETP [the
reticulocytes percent, in [%]]. A short example of use is shown on
Figure 1; detailed information and examples of use are provided
in the help page of the function.
The package also provides a function for calculating the
OFF-score (Gore et al., 2013), another indirect indicator of
blood doping. Also called “OFF-hr score” or “stimulation
index” (Zorzoli, 2011), the OFF-score is part of the Athlete
Biological Passport and is routinely used to identify athletes
who use a substance prohibited by anti-doping rules (CAS,
2016). It combines the hemoglobin level [HGB, [g/dL]] with the
Abbreviations: ABPS, Abnormal Blood Profile Score; ADAMS, Anti-Doping
Administration and Management System; LAD, Swiss Laboratory for Doping
Analyses; WADA, World Anti-Doping Agency.
reticulocytes percent (RETP) using the formula
OFF− score = HGB×10− 60×
√
RETP
The original publication (Gore et al., 2013) provides
thresholds for different populations; OFF-score values typically
range between 85 and 95 and in the worst case scenario (a male
athlete living at low altitude), values over 133 are considered to be
evidence of doping (Marrocco et al., 2012). Note that the original
publication assumed that the hemoglobin level is specified in
g/L; as hemoglobin levels are generally specified in g/dL (for
example, in the ADAMS database) and to ensure coherency with
other functions within the package, our OFF-score function
also expects hemoglobin levels to be specified in g/dL, as for the
ABPS calculation, and it will then convert the units internally (as
shown by the presence of a multiplication by 10 in the formula
above). The OFF-score function will emit a warning if the units
seem wrong.
DATASETS
In addition, the ABPS package provides several datasets linked
to blood doping. The first dataset, named ≪ bloodcontrol ≫,
contains blood parameter data measured on 13 individuals,
provided by the Swiss Laboratory for Doping Analyses (LAD)
in Lausanne. These samples are assumed to represent normal
population, and were not used for fitting the original ABPS
model.
The second dataset, named ≪ blooddoping ≫ contains a
series of 13 measurements of blood parameters conducted over
several years on a female athlete who was later convicted of
repeated doping on the basis of this data (CAS, 2012). The
published data contains some errors (in particular, some values
were swapped between samples) which were discovered while
creating the package and confirmed by WADA. The package
provides a corrected version of the dataset, as well as a detailed
list of the changes that were made.
For both datasets, the OFF-scores and ABPS values provided
were computed by WADA software. The R package can thus
be tested by comparing the results it produces with the ones
computed by WADA.
DOCUMENTATION AND TESTS
The package comes with extensive documentation, in particular
help pages, detailing both the available functions and datasets,
as well as a set of unit tests which verify that the code works as
it should and that it yields the expected results on the provided
datasets. The source code is commented in details and the
package passes all the checks provided by R without any error,
warning or note.
PACKAGE USAGE
The functions provided by the package can be used by
laboratories conducting anti-doping analyses who may want
to calculate ABPS values based on measurements of blood
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FIGURE 1 | A sample session using the ABPS package within R. During this session, the package is installed, loaded, the≪ bloodcontrol≫ dataset is loaded, and
some calculations of ABPS and OFF-score are performed.
parameters they have performed, or by people interested in anti-
doping who want to examine and understand how the ABPS
scheme works, and how sensitive it is to changes in one blood
parameter or another.
However, the most likely use of the package (and the primary
motivation for its creation) is in anti-doping research. As an
example, the ABPSwas used in the past to estimate the prevalence
of doping in different populations of athletes (Sottas et al., 2011b).
In this context, ABPS allows the researcher to work with a single,
combined, parameter instead of seven different markers. The
comparison of its distribution for different groups of interest can
be used to estimate the prevalence of doping. Further research on
this topic has been conducted using this R package and will be
described elsewhere.
LIMITATIONS OF THE PACKAGE
As described above, the package allows a user to calculate the
same ABPS values as available, for example, in the ADAMS
database, thus providing a way to faithfully reproduce these
results. However, as a consequence, the package inherits any
potential shortcomings that the original ABPS algorithm may
have. In particular, the original training dataset was based on
athletes who received rhEPO injections (Sottas et al., 2006), and it
may not be representative of other doping methods. For example,
the ABPSwill lose sensitivity with either volume expansion (IV or
hyper hydration) or sub-micro dose EPOmasking. As the authors
of ABPS note (Sottas et al., 2006), the algorithm may need to be
updated using new datasets when new blood doping methods are
discovered.
The ABPS values are dependent on the blood analyzer used to
generate the measures and are sensitive to bad pre-analytical and
analytical conditions which have an impact on one or more of
the seven hematological markers, such as variation in instrument
calibration; the protocols for collection, transport and analysis
given in the WADA Athlete Biological Passport Operating
Guidelines (WADA, 2018) should be used to guarantee a good
interpretation of ABPS values. In addition, the distribution of
the ABPS values, like the distribution of each of the seven
hematological markers, is dependent on the population studied;
different groups of athletes (for example, males vs. females)
may display different distributions of ABPS values than the one
obtained for the reference population on which the ABPS is
based. For some usages of ABPS (for example, in a study of
the prevalence of doping), it is thus advised to apply correction
factors for the different populations. A future version of the
package will include examples of such corrections, as described
elsewhere (Robinson et al., 2018). It is worth noting that the ABPS
algorithm restricts the possible input values to a range which
depends on the values observed in the original reference dataset.
If a value is outside this range, it will be modified to the minimum
of maximum accepted value; for example, any HGB value lower
than 12.9 or 18.2 will be modified to 12.9, respectively 18.2. The
exact range for each parameter is indicated in the package; a
warning will be printed if an input value is outside the allowed
range.
AVAILABILITY OF THE PACKAGE
The R package is available either from CRAN (Comprehensive
R Archive Network, https://cran.r-project.org/package=ABPS)
or from a git server (https://gitlab.isb-sib.ch/BCF/ABPS). It is
distributed under a free license, the GNU General Public License
(version 2 or later).
In term of dependencies, the ABPS package requires only
one package external to the base R system: kernlab, which is
also available freely (licensed under the GNU GPL version 2) on
CRAN.
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